These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32048780)

  • 1. Potential biomarkers screening to predict side effects of dexamethasone in different cancers.
    Jiang D; Jin H; Zuo J; Kong Y; Zhang X; Dong Q; Xu Z; Li Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1160. PubMed ID: 32048780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer.
    Liu RJ; Li SY; Liu LQ; Xu B; Chen M
    Bioengineered; 2021 Dec; 12(1):2377-2388. PubMed ID: 34077304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Bioinformatics Analysis of Potential Biomarkers for Prostate Cancer.
    Tan J; Jin X; Wang K
    Pathol Oncol Res; 2019 Apr; 25(2):455-460. PubMed ID: 29260398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
    Li HY; Jin N; Han YP; Jin XF
    Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis.
    Zhang Y; Yang A; Huang J
    Med Sci Monit; 2019 Jul; 25():5501-5509. PubMed ID: 31339875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-Based Gene Expression Analysis Identifies Potential Diagnostic and Prognostic Biomarkers for Waldenström Macroglobulinemia.
    Xu H; Yao F
    Acta Haematol; 2018; 140(2):87-96. PubMed ID: 30227405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening prognosis-related genes in glioblastoma by microarray analysis.
    Wang H; Zhang Y; Zhang C; Tong X
    Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.